49 related articles for article (PubMed ID: 34131942)
1. Omecamtiv mecarbil does not prolong QTc intervals at therapeutic concentrations.
Trivedi A; Hsu CP; Jafarinasabian P; Terminello B; Zhang H; Flach S; Israel S; Brooks A; Xue H; Darpo B; Abbasi S; Dutta S; Lee E
Br J Clin Pharmacol; 2022 Jan; 88(1):187-198. PubMed ID: 34131942
[TBL] [Abstract][Full Text] [Related]
2. Effect of single doses of maraviroc on the QT/QTc interval in healthy subjects.
Davis JD; Hackman F; Layton G; Higgins T; Sudworth D; Weissgerber G
Br J Clin Pharmacol; 2008 Apr; 65 Suppl 1(Suppl 1):68-75. PubMed ID: 18333868
[TBL] [Abstract][Full Text] [Related]
3. Effects of triclabendazole and its metabolite exposure on the heart-rate-corrected QT intervals: A randomized, placebo- and positive-controlled thorough QT study in healthy individuals.
Prince WT; Venishetty VK; Lecot J; Shakeri-Nejad K; Gray C; Taylor A; Iyer GR; Zack J
Clin Transl Sci; 2023 Oct; 16(10):1758-1767. PubMed ID: 37688315
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Evaluation of Etrasimod, a Selective Sphingosine 1-phosphate Receptor Modulator, in Healthy Adults: Results of a Randomized, Thorough QT/QTc Study.
Darpo B; Connor K; Cabell CH; Grundy JS
Clin Pharmacol Drug Dev; 2024 Apr; 13(4):326-340. PubMed ID: 38441346
[TBL] [Abstract][Full Text] [Related]
5. No clinically relevant electrocardiogram effects in a randomized TQT study of single therapeutic/supratherapeutic rimegepant doses in healthy adults.
Bhardwaj R; Hanna MS; Morris BA; Matschke KT; Bertz R; Croop RS; Liu J
Clin Transl Sci; 2024 Mar; 17(3):e13727. PubMed ID: 38440916
[TBL] [Abstract][Full Text] [Related]
6. Effect of Tucatinib on Cardiac Repolarization in Healthy Volunteers.
Topletz-Erickson AR; Mayor JG; Liu HT; Abdulrasool LI; Endres CJ
Drugs R D; 2023 Dec; 23(4):411-419. PubMed ID: 37751113
[TBL] [Abstract][Full Text] [Related]
7. Effects of the HIV-1 maturation inhibitor GSK3640254 on QT interval in healthy participants.
Zhang Y; Bush M; Yazdani P; Zhan J; Wen B; Bainbridge V; Wynne BR; Joshi S; Lataillade M
Pharmacol Res Perspect; 2023 Dec; 11(6):e01151. PubMed ID: 37961928
[TBL] [Abstract][Full Text] [Related]
8. Effects of Peginesatide Injection on QTc Interval in Healthy Adults.
Czerniak R; Kukulka M; Wu JT; Qiu P
Clin Pharmacol Drug Dev; 2014 Nov; 3(6):449-455. PubMed ID: 26161294
[TBL] [Abstract][Full Text] [Related]
9. Dostarlimab, an anti-programmed death-1 monoclonal antibody, does not cause QT prolongation in patients with solid tumours: A concentration-QT analysis.
Kuchimanchi M; Dabrowski C; Lu S; Melhem M
Br J Clin Pharmacol; 2023 Jul; 89(7):2272-2282. PubMed ID: 36823349
[TBL] [Abstract][Full Text] [Related]
10. Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Iberdomide.
Cheng Y; Gaudy A; Liu L; Ye Y; Thomas M; Xue Y; Zhou S; Li Y
Clin Pharmacol Drug Dev; 2023 Aug; 12(8):819-825. PubMed ID: 37079714
[TBL] [Abstract][Full Text] [Related]
11. Tigecycline does not prolong corrected QT intervals in healthy subjects.
Korth-Bradley JM; McGovern PC; Salageanu J; Matschke K; Plotka A; Pawlak S
Antimicrob Agents Chemother; 2013 Apr; 57(4):1895-901. PubMed ID: 23403419
[TBL] [Abstract][Full Text] [Related]
12. An open-label, multicenter, phase Ib study investigating the effect of apalutamide on ventricular repolarization in men with castration-resistant prostate cancer.
Belderbos BPSI; de Wit R; Chien C; Mitselos A; Hellemans P; Jiao J; Yu MK; Attard G; Bulat I; Edenfield WJ; Saad F
Cancer Chemother Pharmacol; 2018 Sep; 82(3):457-468. PubMed ID: 29974203
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive in vitro pro-arrhythmic assays demonstrate that omecamtiv mecarbil has low pro-arrhythmic risk.
Qu Y; Gao B; Arimura Z; Fang M; Vargas HM
Clin Transl Sci; 2021 Jul; 14(4):1600-1610. PubMed ID: 33955165
[TBL] [Abstract][Full Text] [Related]
14. Effects of Dihydroartemisinin-Piperaquine Phosphate and Artemether-Lumefantrine on QTc Interval Prolongation.
Funck-Brentano C; Bacchieri A; Valentini G; Pace S; Tommasini S; Voiriot P; Ubben D; Duparc S; Evene E; Felices M; Corsi M
Sci Rep; 2019 Jan; 9(1):777. PubMed ID: 30692558
[TBL] [Abstract][Full Text] [Related]
15. Moxifloxacin Pharmacokinetics, Cardiac Safety, and Dosing for the Treatment of Rifampicin-Resistant Tuberculosis in Children.
Radtke KK; Hesseling AC; Winckler JL; Draper HR; Solans BP; Thee S; Wiesner L; van der Laan LE; Fourie B; Nielsen J; Schaaf HS; Savic RM; Garcia-Prats AJ
Clin Infect Dis; 2022 Apr; 74(8):1372-1381. PubMed ID: 34286843
[TBL] [Abstract][Full Text] [Related]
16. E2027 Cardiac Safety Evaluation With Concentration-Response Modeling of ECG Data to Inform Dose Selection in Studies in Patients With Dementia With Lewy Bodies.
Landry IS; Boyd P; Aluri J; Darpo B; Xue H; Brown R; Reyderman L; Lai R
Alzheimer Dis Assoc Disord; 2022 Jul-Sep 01; 36(3):208-214. PubMed ID: 35622456
[TBL] [Abstract][Full Text] [Related]
17. Assessing QTc Effects of Vericiguat Using Two Different Concentration-QTc Modeling Approaches.
Ruehs H; Solms A; Frei M; Becker C; Trujillo ME; Garmann D; Meyer M
Clin Pharmacokinet; 2023 Nov; 62(11):1639-1648. PubMed ID: 37672197
[TBL] [Abstract][Full Text] [Related]
18. Results of a phase I, open-label, randomized, crossover study evaluating the effects of linifanib on QTc intervals in patients with solid tumors.
Chiu YL; Lorusso P; Hosmane B; Ricker JL; Awni W; Carlson DM
Cancer Chemother Pharmacol; 2014 Jan; 73(1):213-7. PubMed ID: 24241212
[TBL] [Abstract][Full Text] [Related]
19. Concentration-QTc Relationship from a Single Ascending Dose Study of ANAVEX3-71, a Novel Sigma-1 Receptor and Allosteric M1 Muscarinic Receptor Agonist in Development for the Treatment of Frontotemporal Dementia, Schizophrenia, and Alzheimer's Disease.
Fadiran EO; Hammond E; Tran J; Xue H; Chen J; Kaufmann WE; Missling CU; Darpo B
Clin Pharmacol Drug Dev; 2023 Sep; 12(9):888-901. PubMed ID: 37515316
[TBL] [Abstract][Full Text] [Related]
20. Insights into the Mechanism of the Cardiac Drug Omecamtiv Mecarbil─A Computational Study.
Chakraborti A; Tardiff JC; Schwartz SD
J Phys Chem B; 2022 Dec; 126(48):10069-10082. PubMed ID: 36448224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
